Vericel (FRA:ATQP) Accumulated other comprehensive income (loss) : €0.1 Mil (As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is Vericel Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Vericel's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was €0.1 Mil.

Vericel's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2024 (€0.3 Mil) to Dec. 2024 (€0.0 Mil) but then increased from Dec. 2024 (€0.0 Mil) to Mar. 2025 (€0.1 Mil).

Vericel's annual Accumulated other comprehensive income (loss) increased from Dec. 2022 (€-0.9 Mil) to Dec. 2023 (€-0.1 Mil) and increased from Dec. 2023 (€-0.1 Mil) to Dec. 2024 (€0.0 Mil).

Vericel Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Vericel's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vericel Accumulated other comprehensive income (loss) Chart

Vericel Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

0.01

-0.14

-0.92

-0.09

Vericel Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-0.23	-0.25	0.32	-	0.13

Vericel Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Vericel Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Vericel's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Vericel Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vericel Corp (FRA:ATQP) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

VCEL:USA

Address

64 Sidney Street, Cambridge, MA, USA, 02139

Website

https://www.vcel.com

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Vericel Headlines

No Headlines